Industry News

Curated for Orthogate.org Members

EXECUTIVE SUMMARY

• Meduloc Secures $4M Series B Funding for Surgical Fixation Alpha Launch: Orthopaedic medtech developer Meduloc closed a $4 million Series B financing round to drive the controlled alpha launch of its next-generation surgical bone fixation technology.
• Shoulder Innovations Strengthens Commercial Leadership:Shoulder Innovations announced the promotion of Jon Osborne to Chief Commercial Officer, accelerating commercial deployment of its InSet™ Shoulder System.
• ASC Navigation & SI Fusion Advancements:OrthAlign's handheld Lantern® ASC navigation platform and Tenon Medical's Catamaran® SI Joint Fusion System continue commercial scaling across ambulatory surgery centers.

DAILY ANNOUNCEMENTS BY CATEGORY

Surgical Robotics, AI & Navigation

OrthAlign — Commercial Rollout Acceleration of Lantern® ASC Handheld Navigation

• Summary: OrthAlign is expanding commercial deployment of its handheld, non-robotic Lantern® ASC navigation system following FDA 510(k) clearance. Designed specifically for outpatient ambulatory surgery centers, Lantern ASC pairs reusable navigation units with procedural Smart Pack Kits to deliver real-time surgical precision in total knee, partial knee, and revision procedures without heavy capital expenditure.
• Key Details:
  • Device/System Name: Lantern® ASC System
  • Status: Commercial Deployment / FDA 510(k) Cleared
  • Clinical Significance: Offers sub-millimeter resecting precision and gap balancing equal to heavy robotic systems at a lower cost structure suitable for ASC workflows.
• Original Source:OrthAlign Press Release

Joint Reconstruction (Hip, Knee, Shoulder)

Shoulder Innovations — Appoints Jon Osborne as Chief Commercial Officer

• Summary: Shoulder Innovations announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 2026. Osborne will lead global sales, marketing, and commercial execution for the company's proprietary InSet™ Shoulder System platform, which addresses Glenoid component loosening in shoulder arthroplasty.
• Key Details:
  • Device/System Name: InSet™ Shoulder System
  • Status: Executive Leadership / Commercial Scaling
  • Clinical Significance: Supports expanded surgeon education and market access for inlay glenoid technology, targeting long-term fixation durability in total shoulder replacement.
• Original Source:Orthopedics This Week Announcement

Spine & Orthobiologics

Tenon Medical — Commercial Milestones for Catamaran® SI Joint Fusion System

• Summary: Tenon Medical announced corporate updates following FDA 510(k) clearance for its Catamaran® Sacroiliac (SI) Joint Fusion System. The system utilizes a single-transfixion graft architecture designed to stabilize the SI joint along its inferior trajectory, minimizing tissue disruption and operating room duration.
• Key Details:
  • Device/System Name: Catamaran® SI Joint Fusion System
  • Status: Commercial Operations / FDA 510(k) Cleared
  • Clinical Significance: Provides robust structural graft transfixion across the SI joint, lowering post-operative recovery times and surgical morbidity in outpatient spine procedures.
• Original Source:Tenon Medical Corporate Announcement

Corporate, M&A & Regulatory

Meduloc — Closes $4M Series B Financing for Controlled Alpha Launch

• Summary: Meduloc closed a $4.0 million Series B equity round to fund clinical evaluation and early commercial rollout of its proprietary orthopaedic fixation platform. The technology focuses on enhancing primary mechanical stability in compromised bone stock.
• Key Details:
  • Device/System Name: Meduloc Surgical Fixation System
  • Status: Series B Funding / Controlled Alpha Launch
  • Clinical Significance: Addresses mechanical failure rates in osteoporotic fracture fixation and revision reconstructive surgery.
• Original Source:Becker's Spine Review Update

AAOS & MSIS — Joint Virtual Symposium on Periprosthetic Joint Infection (PJI)

• Summary: The American Academy of Orthopaedic Surgeons (AAOS) and the Musculoskeletal Infection Society (MSIS) are hosting a virtual clinical symposium on August 11, 2026, highlighting diagnostic protocols, next-gen synovial biomarkers, and two-stage revision algorithms for periprosthetic joint infections.
• Key Details:
  • Device/System Name: AAOS / MSIS Clinical Practice Guidelines
  • Status: Clinical Symposium / Educational Initiative
  • Clinical Significance: Advances standardized diagnostic and therapeutic algorithms for complex total joint revision cases.
• Original Source:AAOS Official Calendar

NEW FDA 510(k) & PMA CLEARANCE LISTING (PAST 24–48 HOURS)